Vir Biotechnology (VIR)
(Real Time Quote from BATS)
$8.87 USD
-0.08 (-0.89%)
Updated Jun 21, 2024 11:04 AM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.93 |
EPS Last Quarter | -0.48 |
Last EPS Surprise | 51.52% |
ABR | 1.78 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.57 |
Next Year | -3.82 |
EPS (TTM) | -4.01 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 10.90M | 10.68M | 85.27M | 65.06M |
# of Estimates | 3 | 3 | 4 | 3 |
High Estimate | 21.30M | 21.40M | 138.80M | 106.20M |
Low Estimate | 5.17M | 5.17M | 56.40M | 21.13M |
Year ago Sales | 3.80M | 2.64M | 86.18M | 85.27M |
Year over Year Growth Est. | 186.84% | 304.39% | -1.06% | -23.70% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.93 | -0.96 | -3.57 | -3.82 |
# of Estimates | 5 | 4 | 6 | 6 |
Most Recent Consensus | -1.10 | -1.16 | -3.13 | -3.10 |
High Estimate | -0.86 | -0.83 | -3.13 | -3.10 |
Low Estimate | -1.10 | -1.16 | -4.03 | -4.65 |
Year ago EPS | -1.45 | -1.22 | -4.59 | -3.57 |
Year over Year Growth Est. | 35.86% | 21.31% | 22.22% | -7.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 5 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.93 | -0.96 | -3.57 | -3.82 |
7 Days Ago | -0.93 | -0.96 | -3.57 | -3.82 |
30 Days Ago | -0.93 | -0.96 | -3.42 | -3.74 |
60 Days Ago | -1.03 | -1.04 | -4.04 | -3.87 |
90 Days Ago | -1.03 | -1.04 | -4.04 | -3.87 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.93 | -0.96 | -3.93 | -3.88 |
Zacks Consensus Estimate | -0.93 | -0.96 | -3.57 | -3.82 |
Earnings ESP | 0.00% | 0.00% | -10.03% | -1.53% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.48 | -0.86 | -1.22 | -1.45 | NA |
Estimate | -0.99 | -1.14 | -1.21 | -1.21 | NA |
Difference | 0.51 | 0.28 | -0.01 | -0.24 | 0.14 |
Surprise | 51.52% | 24.56% | -0.83% | -19.83% | 13.86% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more